Jun 08, 2023 / 06:00PM GMT
Eun Yang - Jefferies & Company - Analyst
Good afternoon, everybody. This is Eun Yang, a biotech analyst with the Jefferies, based in New York. Next presenting company is Dyne Therapeutics. And this is going to be a fireside chat. Joining me from Dyne are Josh Brumm, President and CEO, and Wildon Farwell, CMO of the company. So, thank you for joining us.
Josh Brumm - Dyne Therapeutics, Inc. - President and CEO
Thank you, Eun.
Wildon Farwell - Dyne Therapeutics, Inc. - Chief Medical Officer
Thank you.
Eun Yang - Jefferies & Company - Analyst
So before we start the Q&A, Josh, would you give us a kind of a brief overview of what Dyne does?
Josh Brumm - Dyne Therapeutics, Inc. - President and CEO
Well, thanks. Thanks again for inviting us here to the conference, Eun and Jefferies. I'm making some forward-looking statements, so please refer to our SEC filings on that matter.
Look, Dyne has been for me, personally,
Dyne Therapeutics Inc at Jefferies Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers